CALR and colorectal cancer: Oxaliplatin but not cisplatin was shown to trigger immunogenic cell death of colorectal cancer cells, activated dendritic cells by expressing danger signals such as heat shock proteins, calreticulin, HMGB1, and efficiently generated a pool of tumor antigen-specific T cells [39].